Aerosolization of nanoparticle suspensions in ethanol using Mystic™ drug delivery technology

A. L. Cowan, D. O. Pontious, D. T. Palmer (Columbus, United States Of America)

Source: Annual Congress 2002 - Bronchial responsiveness, nebulization, devices and airway inflammation
Session: Bronchial responsiveness, nebulization, devices and airway inflammation
Session type: Thematic Poster Session
Number: 3357
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. L. Cowan, D. O. Pontious, D. T. Palmer (Columbus, United States Of America). Aerosolization of nanoparticle suspensions in ethanol using Mystic™ drug delivery technology. Eur Respir J 2002; 20: Suppl. 38, 3357

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Medical nanoparticles for next generation drug delivery to the lungs
Source: Eur Respir J 2014; 44: 765-774
Year: 2014



Effect of device and formulation on delivery of budesonide suspensions by nebulizers
Source: Eur Respir J 2002; 20: Suppl. 38, 542s
Year: 2002

A preliminary assessment of the stability of 5-CF containing liposomes following aerosolisation with TouchSprayÔ technology and a commercial jet nebuliser
Source: Eur Respir J 2003; 22: Suppl. 45, 471s
Year: 2003

Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung
Source: Annual Congress 2009 - New drugs for airways disease
Year: 2009


Electrohydrodynamic atomization of drug solutions for inhalation purposes
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001

A novel submicron budesonide suspension demonstrates equivalent nebulization times compared to cyclodextrin-based solution formulations
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Polyacrylate nanoparticles: toxicity or new nanomedicine?
Source: Eur Respir J 2010; 36: 218-221
Year: 2010


Validation of monodisperse corticosteroid aerosols for in-vivo delivery
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008


The comparison of dispersed compositions of drug aerosols generated from an aqueous suspension, aqueous and glycolic solutions
Source: Eur Respir J 2004; 24: Suppl. 48, 584s
Year: 2004

Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Improvement of QVAR delivery through a better sorting of drug particles: development of an innovative and easy-to-use spacer
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Aerosol delivery
Source: Annual Congress 2013 –PG4 How to build an experimental animal lung lab
Year: 2013

Delivery efficiency of electronic and jet nebulisers aerosolising a colistimethate sodium solution
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009

Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Bioequivalence of a new formulation of omalizumab, solution for injection in prefilled syringe, to the current lyophilized formulation
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Investigation of Beclason efficiency in new delivery device Easi-breathe
Source: Eur Respir J 2002; 20: Suppl. 38, 499s
Year: 2002

Development of a powder for inhalation with R,R-Glycopyrrolate as active ingredient for the delivery from a novel multidose dry powder inhaler
Source: Eur Respir J 2003; 22: Suppl. 45, 471s
Year: 2003

The generation of monodisperse pharmacological aerosols using a spinning-top aerosol generator (STAG)
Source: Eur Respir J 2005; 26: Suppl. 49, 125s
Year: 2005

Drug loaded liposomes of mesalamine incorporated into disease responsive microgels (Micro) for treating allergic asthma: An approach using smart drug delivery system
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015